Microarray analysis (and confirmatory quantitative real-time polymerase chain reaction analysis) of breast cancer samples show the upregulation of Cx26 during progression from ductal carcinoma in situ to invasive ductal carcinoma [69]. Here, GJB2 is linked to breast carcinoma.